Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989
- PMID: 1558973
Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989
Abstract
No reports of the incidence rates for primary systemic amyloidosis (AL) have come to our attention. Records of all residents of Olmstead County, Minnesota, with a diagnosis of amyloidosis were obtained from the Mayo Clinic and its affiliated hospitals, as well as other medical groups that might have seen local patients for the period January 1, 1950 to December 31, 1989. Twenty-one patients fulfilled the criteria for the diagnosis of AL. The median age was 73.5 years, and 62% were men. In all but one patient the diagnosis was made ante mortem. The clinical data of the 21 patients were similar to those referral patients with AL seen at Mayo Clinic. Immunohistochemical stains were positive for monoclonal light chains in the amyloid deposits in 15 of the 21 cases. In six cases, tissue was not available for immunohistochemical studies. Three of the six patients without immunohistochemical stains had a free monoclonal lambda light chain in the urine, and the other three had a monoclonal serum protein. Immunoelectrophoresis/immunofixation detected a monoclonal (M)-protein in the serum of 16 of 17 patients tested. A monoclonal light chain was found in the urine of 10 of 15 patients. The overall sex- and age-adjusted rate per million person-years was 6.1 from 1950 to 1969 and 10.5 from 1970 to 1989. The similarity of these rates suggests no significant increase over time.
Comment in
-
Bence Jones protein in primary systemic amyloidosis.Blood. 1993 Jan 15;81(2):564-5. Blood. 1993. PMID: 8422475 No abstract available.
Similar articles
-
Incidence of AL Amyloidosis in Olmsted County, Minnesota, 1990 through 2015.Mayo Clin Proc. 2019 Mar;94(3):465-471. doi: 10.1016/j.mayocp.2018.08.041. Epub 2019 Jan 31. Mayo Clin Proc. 2019. PMID: 30713046 Free PMC article.
-
Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine.Clin Chem. 2009 Mar;55(3):499-504. doi: 10.1373/clinchem.2008.117143. Epub 2009 Jan 8. Clin Chem. 2009. PMID: 19131635
-
kappa/lambda index for confirming urinary free light chain in amyloidosis AL and other plasma cell dyscrasias.Clin Chem. 1991 Jun;37(6):1122-6. Clin Chem. 1991. PMID: 1904799
-
Immunoglobulin-related (AL) amyloidosis.Clin Exp Rheumatol. 1983 Oct-Dec;1(4):353-8. Clin Exp Rheumatol. 1983. PMID: 6442636 Review.
-
Monoclonal gammopathy of undetermined significance.Clin Lymphoma Myeloma. 2005 Sep;6(2):102-14. doi: 10.3816/CLM.2005.n.036. Clin Lymphoma Myeloma. 2005. PMID: 16231848 Review.
Cited by
-
Autologous Stem Cell Transplant in Hodgkin's and Non-Hodgkin's Lymphoma, Multiple Myeloma, and AL Amyloidosis.Cells. 2023 Dec 18;12(24):2855. doi: 10.3390/cells12242855. Cells. 2023. PMID: 38132175 Free PMC article. Review.
-
Cardiovascular Magnetic Resonance for the Differentiation of Left Ventricular Hypertrophy.Curr Heart Fail Rep. 2020 Oct;17(5):192-204. doi: 10.1007/s11897-020-00481-z. Curr Heart Fail Rep. 2020. PMID: 32844347 Free PMC article. Review.
-
Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies.J Clin Med. 2021 May 1;10(9):1954. doi: 10.3390/jcm10091954. J Clin Med. 2021. PMID: 34062949 Free PMC article. Review.
-
Amyloidosis.Curr Treat Options Oncol. 2006 May;7(3):225-36. doi: 10.1007/s11864-006-0015-8. Curr Treat Options Oncol. 2006. PMID: 16615878 Review.
-
Lingual liability: macroglossia and dyspnoea as the harbinger of systemic AL (light-chain) cardiac amyloidosis.BMJ Case Rep. 2018 Dec 22;11(1):e225923. doi: 10.1136/bcr-2018-225923. BMJ Case Rep. 2018. PMID: 30580294 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical